Combined Diabetes Drugs Linked to Lower Death and Kidney Failure Risk
A nationwide cohort study in Israel found that combining SGLT2 inhibitors with GLP-1 receptor agonists was associated with reduced risks ...
A nationwide cohort study in Israel found that combining SGLT2 inhibitors with GLP-1 receptor agonists was associated with reduced risks ...
A systematic review indicates that SGLT2 inhibitors reduce left ventricular mass and improve diastolic filling pressures in early preclinical heart ...
A scoping review finds SGLT2 inhibitors are associated with reduced gout flares, lower uric acid levels, and decreased mortality in ...
A review in Cardiovascular Diabetology suggests that inducible SGLT2 expression in vascular tissues may drive endothelial dysfunction and amplify cardiovascular ...
A large propensity score-matched study reveals that super-elderly diabetes patients initiating SGLT2 inhibitors experienced significantly fewer falls, fractures, and kidney ...
Computer simulations rank two plant-derived molecules as the strongest binders to PPARγ and SGLT2 receptors linked to type 2 diabetes, ...
A retrospective study of 150 Chinese heart-failure patients found that adding dapagliflozin to sacubitril-valsartan was associated with better cardiac-function measures, ...
A small clinical case series suggests SGLT2 inhibitors may directly enhance peritoneal dialysis ultrafiltration, offering a potential new strategy for ...
Researchers have shown for the first time at single-cell resolution that the SGLT2 gene is expressed in thirst-promoting NOS1 neurons ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine